Bijvank E - Search Results

1

Identification of aging-associated immunotypes and immune stability as indicators of post-vaccination immune activation.

Cevirgel A, Shetty SA, Vos M, Nanlohy NM, Beckers L, Bijvank E, Rots N, van Beek J, Buisman AM, van Baarle D. Cevirgel A, et al. Among authors: bijvank e. Aging Cell. 2022 Oct;21(10):e13703. doi: 10.1111/acel.13703. Epub 2022 Sep 8. Aging Cell. 2022. PMID: 36081314 Free PMC article.

2

Associations and recovery dynamics of the nasopharyngeal microbiota during influenza-like illness in the aging population.

Shetty SA, van Beek J, Bijvank E, Groot J, Kuiling S, Bosch T, van Baarle D, Fuentes S. Shetty SA, et al. Among authors: bijvank e. Sci Rep. 2022 Feb 3;12(1):1915. doi: 10.1038/s41598-022-05618-9. Sci Rep. 2022. PMID: 35115596 Free PMC article.

3

Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands.

van den Hoogen LL, Boer M, Postema A, de Rond L, de Zeeuw-Brouwer ML, Pronk I, Wijmenga-Monsuur AJ, Bijvank E, Kruiper C, Beckers L, Maurik MB, Zutt I, van Vliet J, van Bergen R, Kuijer M, Smits G, Verschuren WMM, Picavet HSJ, van der Klis FRM, den Hartog G, van Binnendijk RS, Buisman AM. van den Hoogen LL, et al. Among authors: bijvank e. Vaccines (Basel). 2022 Sep 6;10(9):1480. doi: 10.3390/vaccines10091480. Vaccines (Basel). 2022. PMID: 36146557 Free PMC article.

4

Pre-vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination.

Cevirgel A, Shetty SA, Vos M, Nanlohy NM, Beckers L, Bijvank E, Rots N, van Beek J, Buisman AM, van Baarle D. Cevirgel A, et al. Among authors: bijvank e. Aging Cell. 2024 Feb;23(2):e14048. doi: 10.1111/acel.14048. Epub 2023 Dec 25. Aging Cell. 2024. PMID: 38146131 Free PMC article.

5

Serological profiling of pneumococcal proteins reveals unique patterns of acquisition, maintenance and waning of antibodies throughout life.

He SWJ, Voß F, Nicolaie MA, Brummelman J, van de Garde MDB, Bijvank E, Poelen M, Wijmenga-Monsuur AJ, Wyllie AL, Trzciński K, Van Beek J, Rots NY, den Hartog G, Hammerschmidt S, van Els CACM. He SWJ, et al. Among authors: bijvank e. J Infect Dis. 2024 Apr 29:jiae216. doi: 10.1093/infdis/jiae216. Online ahead of print. J Infect Dis. 2024. PMID: 38679601

6

Euchromatin histone methyltransferase 1 regulates cortical neuronal network development.

Martens MB, Frega M, Classen J, Epping L, Bijvank E, Benevento M, van Bokhoven H, Tiesinga P, Schubert D, Nadif Kasri N. Martens MB, et al. Among authors: bijvank e. Sci Rep. 2016 Oct 21;6:35756. doi: 10.1038/srep35756. Sci Rep. 2016. PMID: 27767173 Free PMC article.

7

Evaluation of a face-to-face psychosocial screening intervention for cancer patients: acceptance and effects on quality of life.

Bramsen I, van der Linden MH, Eskens FJ, Bijvank EM, van Groeningen CJ, Kaufman HJ, Aaronson NK. Bramsen I, et al. Among authors: bijvank em. Patient Educ Couns. 2008 Jan;70(1):61-8. doi: 10.1016/j.pec.2007.09.010. Epub 2007 Nov 7. Patient Educ Couns. 2008. PMID: 17997260 Clinical Trial.

8

Phase II study of interferon-gamma and interleukin-2: tachyphylaxis of toxicity to the liver during increasing immune enhancement.

Baars JW, Wagstaff J, Van Groeningen CJ, Vermorken JB, Bijvank EM, Pinedo HM, Nauta JJ. Baars JW, et al. Among authors: bijvank em. J Natl Cancer Inst. 1993 Mar 3;85(5):410-1. doi: 10.1093/jnci/85.5.410. J Natl Cancer Inst. 1993. PMID: 8433395 Clinical Trial. No abstract available.

9

[Interleukin-2].

Bijvank E, van Loo J. Bijvank E, et al. TVZ. 1988 Mar 3;42(5):154-7. TVZ. 1988. PMID: 3128894 Dutch. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page